Global leader in therapeutic ultrasound for 40 years, EDAP TMS (NASDAQ: EDAP) develops, manufactures, promotes and distributes minimally invasive and innovative medical devices using ultrasound technology. Actively operating worldwide via an extensive network of subsidiaries, corporate offices, and distribution partners, EDAP TMS is currently marketing two ranges of urology products dedicated to localized prostate cancer and urinary stones. EDAP TMS is also developing its innovative technologies to expand applications beyond urology.
By combining the latest technologies in imaging and treatment modalities, EDAP TMS introduced the Focal One® as the answer to all requirements for ideal focal therapy of prostate cancer as a complement to the existing Ablatherm® HIFU device.
As a pioneer and key player in the field of extracorporeal lithotripsy (ESWL), EDAP TMS exclusively utilizes the latest generation of shock wave source in its Sonolith® range of ESWL systems.
Brands: Focal One / Ablatherm Fusion / Endo-UP / Sonolith i-move / Laserlith i-dust